Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Mar-24 5:40 PM View:  | DexCom, Inc. (DXCM) | 12-Mar-24 | Sale | 11,661 | $134.41 | $1,567,360.00 | (12%) 97.19K to 85.53K | |
| 11-Mar-24 6:32 PM View: | DexCom, Inc. (DXCM) | 08-Mar-24 | Grant | 26,053 | -- | -- | 37% 71.14K to 97.19K | |
| 21-Feb-24 5:48 PM View: | DexCom, Inc. (DXCM) | 20-Feb-24 | Sale (Planned) | 3,363 | $116.73 | $392,563.00 | (5%) 74.5K to 71.14K | |
| 17-Jan-24 6:54 PM View: | DexCom, Inc. (DXCM) | 16-Jan-24 | Sale | 2,734 | $123.64 | $338,018.00 | (4%) 77.24K to 74.5K | |
| 17-Jan-24 6:54 PM View: | DexCom, Inc. (DXCM) | 12-Jan-24 | Grant | 7,171 | $0.00 | $7.17 | 10% 70.07K to 77.24K | |
| 19-Dec-23 4:36 PM View: | DexCom, Inc. (DXCM) | 18-Dec-23 | Disposition | 2,932 | $121.85 | $357,261.00 | (4%) 73.0K to 70.07K | |
| 22-Aug-23 4:04 PM View: | DexCom, Inc. (DXCM) | 22-Aug-23 | Sale (Planned) | 1,844 | $104.38 | $192,477.00 | (2%) 74.71K to 72.87K | |
| 23-May-23 7:12 PM View: | DexCom, Inc. (DXCM) | 22-May-23 | Sale (Planned) | 2,400 | $117.58 | $282,192.00 | (3%) 77.11K to 74.71K | |
| 14-Mar-23 4:53 PM View: | DexCom, Inc. (DXCM) | 10-Mar-23 | Disposition | 9,618 | $111.40 | $1,071,440.00 | (11%) 86.73K to 77.11K | |
| 10-Mar-23 3:57 PM View: | DexCom, Inc. (DXCM) | 08-Mar-23 | Grant | 21,769 | $0.00 | $21.77 | 34% 64.96K to 86.73K | |
| 22-Feb-23 6:08 PM View: | DexCom, Inc. (DXCM) | 22-Feb-23 | Sale (Planned) | 2,400 | $114.54 | $274,896.00 | (4%) 67.24K to 64.84K | |
| 22-Nov-22 6:25 PM View: | DexCom, Inc. (DXCM) | 21-Nov-22 | Sale (Planned) | 2,400 | $112.62 | $270,288.00 | (3%) 69.64K to 67.24K | |
| 06-Jun-22 4:52 PM View: | DexCom, Inc. (DXCM) | 06-Jun-22 | Sale (Planned) | 600 | $301.57 | $180,942.00 | (3%) 18.01K to 17.41K | |
| 10-Mar-22 7:31 PM View: | DexCom, Inc. (DXCM) | 09-Mar-22 | Disposition | 1,951 | $406.06 | $792,217.00 | (10%) 19.96K to 18.01K | |
| 10-Mar-22 7:31 PM View: | DexCom, Inc. (DXCM) | 08-Mar-22 | Grant | 5,297 | $0.00 | $5.30 | 36% 14.66K to 19.96K | |
| 04-Mar-22 7:02 PM View: | DexCom, Inc. (DXCM) | 04-Mar-22 | Market Sale (Planned) | 600 | $422.94 | $253,764.00 | (4%) 15.26K to 14.66K | (9%) |
| 17-Dec-21 4:40 PM View: | DexCom, Inc. (DXCM) | 15-Dec-21 | Grant | 2,925 | $0.00 | $2.92 | 24% 12.29K to 15.22K | |
| 06-Dec-21 7:16 PM View: | DexCom, Inc. (DXCM) | 06-Dec-21 | Market Sale (Planned) | 600 | $517.59 | $310,554.00 | (5%) 12.89K to 12.29K | (< 1%) |
| 10-Nov-21 7:10 PM View: | DexCom, Inc. (DXCM) | 09-Nov-21 | Grant | 634 | $634.12 | $402,032.00 | (5%) 13.53K to 12.89K | (< 1%) |
| 13-Sep-21 8:01 PM View: | DexCom, Inc. (DXCM) | 09-Sep-21 | Market Sale | 407 | $541.36 | $220,336.00 | (3%) 13.93K to 13.53K | (1%) |
| 08-Sep-21 6:54 PM View: | DexCom, Inc. (DXCM) | 07-Sep-21 | Market Sale (Planned) | 587 | $545.41 | $320,156.00 | (4%) 14.52K to 13.93K | (1%) |
| 26-May-21 4:58 PM View: | DexCom, Inc. (DXCM) | 24-May-21 | Market Sale (Planned) | 600 | $346.74 | $208,044.00 | (4%) 15.11K to 14.51K | (2%) |
| 12-Mar-21 5:42 PM View: | DexCom, Inc. (DXCM) | 10-Mar-21 | Market Sale | 941 | $362.92 | $341,505.00 | (6%) 16.05K to 15.11K | (1%) |
| 10-Mar-21 7:30 PM View: | DexCom, Inc. (DXCM) | 08-Mar-21 | Grant | 5,301 | $0.00 | $5.30 | 49% 10.75K to 16.05K | |
| 26-Feb-21 6:02 PM View: | DexCom, Inc. (DXCM) | 24-Feb-21 | Market Sale (Planned) | 600 | $404.00 | $242,400.00 | (5%) 11.3K to 10.7K | 2% |
| 25-Nov-20 4:50 PM View: | DexCom, Inc. (DXCM) | 24-Nov-20 | Market Sale (Planned) | 600 | $320.37 | $192,222.00 | (5%) 11.9K to 11.3K | |
| 12-Nov-20 5:39 PM View: | DexCom, Inc. (DXCM) | 10-Nov-20 | Market Sale | 632 | $336.22 | $212,491.00 | (5%) 12.53K to 11.9K | |
| 11-Sep-20 6:59 PM View: | DexCom, Inc. (DXCM) | 09-Sep-20 | Market Sale | 289 | $398.30 | $115,109.00 | (2%) 12.82K to 12.53K | |
| 26-Aug-20 7:04 PM View: | DexCom, Inc. (DXCM) | 24-Aug-20 | Market Sale (Planned) | 600 | $427.41 | $256,446.00 | (4%) 13.42K to 12.82K | |
| 13-Mar-20 9:17 PM View: | DexCom, Inc. (DXCM) | 11-Mar-20 | Market Sale | 613 | $264.83 | $162,340.00 | (4%) 14.03K to 13.42K | |
| 10-Mar-20 8:23 PM View: | DexCom, Inc. (DXCM) | 08-Mar-20 | Grant | 5,483 | $0.00 | $5.48 | 64% 8.55K to 14.03K | |
| 05-Feb-18 5:59 PM View: | NuVasive, Inc. (NUVA) | 01-Feb-18 | Payment of Exercise | 380 | $48.50 | $18,430.00 | (5%) 8.32K to 7.94K | (21%) |
| 05-Feb-18 5:59 PM View: | NuVasive, Inc. (NUVA) | 01-Feb-18 | Option Exercise | 931 | -- | -- | 13% 7.39K to 8.32K | |
| 05-Jul-17 5:53 PM View: | NuVasive, Inc. (NUVA) | 01-Jul-17 | Payment of Exercise | 785 | $76.92 | $60,382.20 | (10%) 8.18K to 7.39K | 24% |
| 05-Jul-17 5:53 PM View: | NuVasive, Inc. (NUVA) | 01-Jul-17 | Option Exercise | 2,091 | -- | -- | 34% 6.09K to 8.18K | |
| 03-Feb-17 6:03 PM View: | NuVasive, Inc. (NUVA) | 01-Feb-17 | Payment of Exercise | 407 | $70.76 | $28,799.30 | (7%) 6.06K to 5.66K | 17% |
| 03-Feb-17 6:03 PM View: | NuVasive, Inc. (NUVA) | 01-Feb-17 | Option Exercise | 931 | -- | -- | 18% 5.13K to 6.06K |